The emergence and spread of antibiotic-resistant bacteria are aggravated by incorrect prescription and use of antibiotics. A core problem is that there is no sufficiently fast diagnostic test to guide correct antibiotic prescription at the point of care. Here, we investigate if it is possible to develop a point-of-care susceptibility test for urinary tract infection, a disease that 100 million women suffer from annually and that exhibits widespread antibiotic resistance. We capture bacterial cells directly from samples with low bacterial counts (10 4 cfu/mL) using a custom-designed microfluidic chip and monitor their individual growth rates using microscopy. By averaging the growth rate response to an antibiotic over many individual cells, we can push the detection time to the biological response time of the bacteria. We find that it is possible to detect changes in growth rate in response to each of nine antibiotics that are used to treat urinary tract infections in minutes. In a test of 49 clinical uropathogenic Escherichia coli (UPEC) isolates, all were correctly classified as susceptible or resistant to ciprofloxacin in less than 10 min. The total time for antibiotic susceptibility testing, from loading of sample to diagnostic readout, is less than 30 min, which allows the development of a point-of-care test that can guide correct treatment of urinary tract infection.
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point of care | UTI | AST | antibiotic | resistance | microfluidic W ith the ever-increasing emergence and spread of antibioticresistant bacteria, a key factor in correct treatment of infections is the ability to rapidly identify the antibiotic susceptibility profile of the infecting species to assure the use of an efficacious antibiotic and reduce the need for broad spectrum drugs (1) (2) (3) . Phenotypic antibiotic susceptibility tests (ASTs) are typically based on the detection of differential bacterial growth with and without antibiotics in liquid cultures or on solid agar plates (4) . In liquid tests, detection is based on the change in OD, whereas the disk diffusion method is used on solid agar plates to identify inhibition zones (5) . These methods are generally reliable for detecting resistance and determining the antibiotic concentration that prevents bacterial growth, making them predictive of the therapeutic utility of different antibiotics. However, because it typically takes 1-2 d to get a reliable readout, these methods fail to guide treatment in the early, often critical, stages of infection. As a consequence, the physician is left with the difficult choice of prescribing a broad spectrum antibiotic or risking that the first prescribed antibiotic is ineffective.
Genotypic ASTs are based on detection of a specific genetic marker (plasmids, genes, or mutations) associated with resistance phenotypes by using the common genetic tools (e.g., sequencespecific amplification by PCR, padlock probe-mediated rolling circle amplification, or whole-genome sequencing) (3, 6) . These tests are highly sensitive and can limit the detection time to what is needed to amplify selected DNA sequences to detectable levels, but they require detailed advance knowledge of which resistance markers to test for. If new resistance mechanisms arise, these would go undetected and result in false negatives. Furthermore, the presence of certain resistance genes/mutations does not necessarily translate into phenotypic resistance.
Unlike the genotypic ASTs, the phenotypic ASTs directly assess if the antibiotic stops bacterial growth, which is the most relevant measure for the treating physician. New phenotypic ASTs have, therefore, been developed in recent years to decrease the detection times. In particular, microfluidics (7) have made it possible to increase the signal to background ratio in the phenotypic assays by miniaturizing the bacterial incubation chambers (8) . Using microfluidic approaches, it has been possible to push the time requirement for AST to 1-3 h (9-13). Recent promising data based on relative DNA copy number increase in antibiotic-treated vs. reference cultures quantified using digital PCR suggest that a biological response can be detected already 15 min after exposure to an antibiotic (14) . However, the PCR step still takes an additional 60 min, making this test too slow for a point-of-care application. Here, we use direct single-cell imaging to show that it is possible to determine if a bacterial isolate is susceptible to an antibiotic in less than 10 min. When we include the time for loading a dilute sample, the total time for the test is less than 30 min, such as would be required for a point-of-care application.
Urinary tract infection (UTI) is one example where a fast AST could improve medical practice by making it possible to prescribe an antibiotic to which the infecting bacteria are susceptible before the patient leaves the primary care unit. A fast AST for UTI would have an important clinical impact given that there are 100 million cases of UTI per year worldwide, with high frequency of resistance to primary antibiotics (15) . Because 85% of all UTI cases diagnosed in primary care are caused by Escherichia coli, we have focused on this species, but the test can be expanded to Significance Antibiotic resistance is a global threat to human health. The problem is aggravated by unnecessary and incorrect use of broad spectrum antibiotics. One way to provide correct treatment and slow down the development of antibiotic resistance is to assay the susceptibility profile of the infecting bacteria before treatment is initiated and let this information guide the choice of antibiotic. Here, we present an antibiotic susceptibility test that is sufficiently fast to be used at the point of care. We show that it is possible to determine if a urinary tract infection is caused by resistant bacteria within 30 min of loading a urine sample, even if the bacterial concentration in the urine is very low.
also include other species. Clinical infections are diagnosed from 10 3 or 10 4 cfu/mL depending on country, which defines the required sensitivity of a test.
Results
Design and Loading of Microfluidic Chip. The microfluidic chip design is shown in Fig. 1 . (More details on the design can be found in SI Materials and Methods and Figs. S1 and S2.) The device has two rows of cell traps. In each row, there are 2,000 cell traps of dimension 1.25 × 1.25 × 50 μm (Fig. 1A) that can be loaded with bacterial cells (red) from the front channel. A constriction at the end of each trap prevents cells from passing to the back channel, while allowing the media to flow around the cells. This sieve-like design, which is an extension of the Mother Machine (16) , enables rapid loading and constant media flow over the cells.
To test how rapidly dilute samples could be loaded, we monitored the fraction of traps loaded over time for different cell cultures with densities from 1,100 to 2 × 10 6 cfu/mL (Fig. 1B) ; 80% of the cell traps were filled within 30 s at a cell density of 2 × 10 6 , and even with the most dilute sample, 1,100 cells per 1 mL, 160 of 2,000 traps were filled in 10 min (SI Materials and Methods and Fig. S3 ).
The loading time curves (Fig. 1B) can be used for real time bacterial density determination (for example, in a urine sample). Within 30 s, it would be possible to assess if it was a severe bacterial infection with more than 10 5 cells per 1 mL, and within 10 min, it would be possible to determine if there is a clinically relevant infection at all (17, 18) .
Growth Rate Measurements. In a typical experiment, fluid control is switched from loading to running mode when there is at least one cell in one-half of the cell traps. This prevents filling the cell traps and allows easy detection of the front end of the cell column. A few seconds after the switch, loading media inflow stops, and test media start to reach the cell trap regions. The reference population row receives the antibiotic-free medium, and the treatment population row receives the media with the antibiotic to be tested ( Fig. 2A) . After the media switch, we performed time-lapse phase contrast microscopy (20× magnification) with an automated x-y translation stage, where each of 4,000 cell traps was imaged every 60 s (a time-lapse movie of one position during a typical experiment can be seen in Movie S1).
Growth rates were first estimated for the cells in each individual cell trap. The movement of the front-most cell pole in each cell trap was monitored as a proxy for the cumulative cell length changes for the cells within that trap. corresponding growth rates for individual traps are shown in Fig.  2F . In Fig. 2G , the growth rates for the individual cell traps from both populations are averaged and normalized by the average growth rate of the reference population. The framewise sample SD is shown in light transparent color in Fig. 2G , and the SEM is used to calculate a 99.9% confidence interval for the average growth rate (darker shaded region in Fig. 2G ). By combining the data from the two columns (Fig. 2H) , we could detect the response of the antibiotic treatment population in this experiment based on divergence from a 99.9% confidence interval (dashed magenta line in Fig. 2H ) earlier than the first data point at ∼5 min. We loaded the bacteria into the microfluidic chip and supplied growth media (GM) without antibiotic to one row (reference population) and GM with antibiotic to the other (treatment population). With this setup, we could detect the differential growth rate between treatment and reference populations in 3 min for CIP, LEV, MEC, NIT, and TMP-SMX; 7 min for AMX-CLA and DOR; 9 min for FOS; and 11 min for ampicillin based on 99.9% confidence intervals (Fig. 3) . Importantly, the response curves were very reproducible between biological replicates, as shown for CIP and ampicillin in SI Materials and Methods and Fig. S4 . This implies that the differential responses to the different drugs were not caused by limited time resolution in the assay but rather, that the measurement was sufficiently fast to monitor the actual biological response time. These experiments were run in the standard susceptibility testing Mueller-Hinton (MH) media; however, in SI Materials and Methods, we show that response times were similar for bacteria grown in urine (Fig. S5) . In SI Materials and Methods and Movies S2 and S3, we also show that the fASTest works on Klebsiella pneumoniae and Staphylococcus saprophyticus, which are two other major pathogens causing uncomplicated UTI. The response time for S. saprophyticus was slower as expected because of its longer generation time (Fig. S6) . directly conclude that a strain is susceptible just because it has impaired growth compared with untreated cells (as seen in Fig. 3 ). For this reason, we first tested CIP susceptibility of an E. coli strain that was genetically engineered to be resistant to ciprofloxacin (CipR) because of the introduction of several clinically observed mutations (gyrA1-S83L gyrA2-D87N parC-S80I) (19) and compared the results with those of the congenic susceptible WT E. coli strain (CipS) (Fig. 4 A and B) . During the first minutes of the test, the CipR strain grew slightly slower when treated with CIP than its untreated reference population (Fig. 4A ) before recovering to the same growth rate. The CipS strain responded more strongly (Fig.  4B) , which made it possible to distinguish the WT strain from its constructed resistant counterpart in a few minutes.
Next, we tested 50 clinical isolates of uropathogenic E. coli (UPEC) strains for CIP susceptibility. Samples were initially collected and characterized by the Uppsala University Hospital Clinical Microbiology Laboratory using the gold standard disk diffusion test for CIP susceptibility/resistance as a part of routine for clinical diagnosis. The antibiotic susceptibility of isolates was tested by the disk diffusion method recommended by the European Committee on Antimicrobial Susceptibility Testing (5). A total of 25 CIP-susceptible and 25 CipR isolates were given to us. We received those samples blinded: without the patient or the CIP susceptibility information. One isolate did not grow in the liquid cultures during the preparations and was, therefore, excluded from the study. The remaining 49 isolates were tested for CIP susceptibility using the fASTest. Subsequently, the results were compared with the results from the hospital.
The fASTest results of 49 UPEC clinical isolates are given in Fig. 4 C-E. The growth rate of the untreated reference population varied between the isolates without any obvious differences between resistant and susceptible isolates (Fig. 4C) . CIP growth rates of treated populations did not reveal a striking distinction between the resistant and the susceptible isolates (Fig.  4D) . However, when the growth rate of the CIP-treated population was normalized with the growth rate of the untreated reference population from the same experiment, susceptible and reference isolates grouped apart after the first 10 min (Fig. 4E) . As can be seen in Fig. 4E , all of 24 resistant strains and 25 susceptible strains were grouped in agreement with gold standard disk diffusion measurements within 10 min. This complete agreement corresponds to 86.28-100.00% sensitivity and 85.75-100.00% specificity for detecting resistance.
Discussion
This study originated in an investigation of the cell to cell variation in the bacterial cell cycle (20) , which required us to develop tools to determine growth rates very accurately for individual E. coli cells. The process of averaging the growth rate from several hundred individual bacteria makes it possible to detect changes in growth as fast as the biological responses to the antibiotic (Fig.  S4) . For this reason, it is not possible to find a phenotypic AST based on the growth rate response that is faster than the fASTest. It is important to note that the same time resolution cannot be achieved in a bulk measurement of the growth rate, because in that case, the averaging is done over the cells before the readout, which means that the unavoidable readout noise will impact the growth rate estimate much more than if it is averaged over the cells after the readout.
The sensitivity of fASTest in terms of how many cells per milliliter can be detected is only dependent on how much time is spent loading the cells. For 10 4 cfu/mL, which is in the lower range for clinically relevant UTIs, sufficient loading can be achieved in 5 min, because for fASTest, it is sufficient to collect ≈100 bacteria. However, the sensitivity will practically depend on which body fluid the sample is collected from. For example, in UTI samples, there may be bacterial contamination from the skin or vaginal flora that sets the sensitivity limit for the infecting species. However, cell traps that contain contaminants may in many cases be excluded based on the morphology and growth rate of the contaminants. A challenge related to contamination is polymicrobial infections. These are rare for uncomplicated UTIs but commonly observed for, for example, catheter users (21). Because we detect all bacteria in the sample and do not only detect those that grow under standard plating assays, polymicrobial infections can be detected as a high diversity of growth rates in the reference channel. If the mixed strains also display a diverse resistance pattern, this would be observed as a broadened growth rate distribution after antibiotic treatment. An actual point-of-care test would, therefore, have to consider other aspects of the growth rate distribution than just the average. There may, for example, be specific automated indications if a few individual bacteria keep growing fast in a background of dying cells, because this may indicate a polymicrobial infection with a complex resistance spectrum. An alternative strategy for the test to deal with polymicrobial infections and contaminations is to make it time sequential, such that the growth rate is determined for the cells in each cell trap before and after antibiotic treatment. This allows for focusing the analysis on only growing cells and avoiding biases in the averaging caused by an uneven distribution of different species between the reference channel and the treatment channel. A test also needs to consider the possible situation where the cells in the reference channel grow so slowly that a lack of response in treatment channel would be unreliable.
We have here focused on bacterial species and antibiotics related to UTIs, but it is likely that the same principles would work for sepsis, mastitis, or meningitis (i.e., in blood, milk, or cerebrospinal fluid that normally should be devoid of bacterialsized cells). Independent of the sample, the key principle will be true: it is sufficient to measure the single-cell growth of a few hundred bacteria to get very close to the theoretical time limit for monitoring the response to an antibiotic in real time.
In summary, samples with more than 10 4 cfu/mL can be loaded in less than 10 min, and thus, no precultivation is needed for patient urine samples. Furthermore, any eukaryotic cell in the sample will be too large to pass through the filtration region within the microfluidic chip or enter the cell channels and disturb the assay. Thus, the combined AST time (loading, measurement, and readout) of the sample is less than 30 min. Based on the small clinical study of CIP susceptibility, the observed sensitivity and specificity of the assay are in 100% agreement with existing but prohibitively slow methodology.
Materials and Methods
The Microfluidic Chip. The microfluidic chip consists of a cover glass (1.5) and a micromolded silicon elastomer [Sylgard 184; polydimethylsiloxane (PDMS)] that are covalently bonded together. For micromolding, we used the standard soft lithography techniques as described in SI Materials and Methods.
fASTest Protocol. All of the fASTest runs described in this paper follow this common protocol: growth of overnight culture (ONC), growth of loading culture, connection of microfluidic flow control setup to the microfluidic chip, aligning the chip to the camera, selection of positions to be imaged, running an imaging test to ensure the stability of the microfluidic chip, connecting the loading culture to the macrofluidic setup, loading the cells from loading culture, and starting the antibiotic application and automated phase contrast microscopy.
Bacterial Strains. The strains used were WT strain DA5438 (E. coli MG1655), ampicillin-resistant strain DA28097 [E. coli del(PlacI_lacIZYA)::amp], CipR strain DA20859 (E. coli gyrA1-S83L, gyrA2-D87N, parC-S80I), and two other species: DA12755 (K. pneumoniae; ATCC13883) and DA14015 (S. saprophyticus).
GM. Depending on the experiment, we used either Mueller-Hinton Broth (70192-500G; Sigma-Aldrich) or urine as GM. When indicated, the GM was supplemented with an antibiotic. In preparation of urine media, morning urine was collected, and filtered (nitrocellulose filter; 0.2-μm pore size). All media are supplemented with a surfactant [Pluronic F-108; 542342; SigmaAldrich; 0.085% (wt/vol) final concentration] to prevent the attachment of the bacteria to the PDMS surface.
Culture Conditions. For ONC, bacteria from the glycerol stocks were inoculated into 2 mL GM and incubated (37°C; shaking at 225 rpm) for ∼16 h. For loading culture, 2.5 μL ONC is diluted 1:800 to a total of 2 mL GM and incubated (37°C; shaking at 225 rpm) for 120 min. For growth in the chip, the chip was continuously supplied with GM and incubated in the microscope cage incubator at 37°C before, during, and after the loading of bacterial culture and also, during the test. The loading culture was connected to the fluidic setup and kept in the cage incubator at 37°C. GM was kept outside of the cage incubator at room temperature (21°C).
Microfluidic Flow Control Setup Details. Flow direction and rate during the experiment were maintained by pressure-driven flow. An electropneumatic controller from Elveflow (OB1 MkIII) regulated the air pressure applied to the closed fluidic reservoirs. Pressures, flow rates, and tubing details are explained in SI Materials and Methods. The electropneumatic controller was programmed in MATLAB.
Automated Phase Contrast Microscopy. We used a Nikon Ti-E inverted microscope with a 20× objective (CFI Plan Apo Lambda DM 20× or CFI S Plan Fluor ELWD ADM 20×), with a motorized x-y stage, and a CMOS camera (DMK23U274; The Imaging Source). The setup was maintained within the Cage Incubator Enclosure (custom made by Okolab), where the temperature was maintained at 37°C by a temperature controller (Airtherm-Atx; World Precision Instruments). Both the microscope and the camera were controlled by an open source microscopy software (MicroManager 1.4.19 ). Phase contrast images were acquired by the software's multidimensional acquisition feature, through which the motorized stage moved the fluidic chip to 36 different positions. Each position was imaged every 30 or 60 s depending on the particular experiment. Each experiment was 30 min, although the imaging could be continued longer if needed to provide insights on kill dynamics.
Image Processing. The images were processed for detection of each row in the raw image and cell traps and empty traps in each row, removing background and performing pole detection to obtain the cell pole detection in each frame of each position using an algorithm developed in MATLAB. Details of this algorithm are given in SI Materials and Methods and Fig. S7 .
Data Analysis. For cell pole tracking, we used μTrack (22) . For growth rate calculation of individual cells, we applied a sliding window of data points (length) and fitted a linear function to the logarithm of them. The sliding window grows from 2 to 10 min in the beginning of the experiment and stays at 10 min afterward. We filtered some data based on fixed criteria to remove misidentified particles or cells that were dead from the beginning as well as the traps that were overly filled or left empty during the loading. Details of filters applied are given in SI Materials and Methods.
All raw data will be made available upon request for noncommercial interests. The ethical review committee in Uppsala has no objection to this study (reference no. 2017/051).
